Document:

Exhibit 4.4

 

EXHIBIT 1

 

Warrant Certificate

 

COMMON STOCK PURCHASE

 

WARRANT LA ROSA HOLDINGS

 

CORP.

	Warrant Shares: [________]	Initial Exercise Date: [___], 2023

 

THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on
[ ], 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from La Rosa Holdings Corp.,
a Nevada corporation (the “Company”), up to [___] shares (as subject to adjustment hereunder, the “Warrant
Shares”) of Common Stock. The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price,
as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry
form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of
this Warrant, subject to a Holder’s right to elect to receive a Warrant in certificated form pursuant to the terms of the
Warrant Agency Agreement, in which case this sentence shall not apply.

 

Section 1. Definitions.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Bid Price”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share so reported, or (d) in all other cases,
the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a
majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be
paid by the Company.

 

“Board of Directors” means the board of
directors of the Company.

 

“Business Day”
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to
remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar
orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers
on such day.

 

“Commission”
means the United States Securities and Exchange Commission. “Common Stock” means the common stock of the Company, par
value $0.0001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

“Common Stock
Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any
time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any
time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

    	 	 	1/16

     

    

 

“Exempt
Issuance” means the issuance of (i) shares of Common Stock or options to employees, officers or directors of the Company
or consultants to the Company pursuant to any stock or option plan or other written agreement duly adopted for such purpose, by
a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
established for such purpose for services rendered to the Company, provided, however, such issuance (A) shall not exceed fifteen
percent (15.0%) of the Common Stock issued and outstanding as of the date hereof, (B) shall be at no less than fair market value
(as measured by the closing price of the Common Stock on the Trading Market on the date of issuance) and (C) in the first year
from the date hereof shall be issued as restricted securities; (ii) securities upon the exercise or exchange of or conversion of
any securities exercisable or exchangeable for or convertible into Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits
or combinations) or to extend the term of such securities; (iii) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company or securities issued in financing transactions, the primary
purpose of which is to finance acquisitions or strategic transactions approved by a majority of the disinterested directors of
the Company, provided that such securities are issued as “restricted securities” (as defined in Rule 144) and carry
no registration rights that require or permit the filing of any registration statement in connection therewith, and provided that
any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the
Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to a person or an entity whose primary business is investing
in securities; (iv) shares of Common Stock, options or convertible securities issued to banks, equipment lessors or other financial
institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction
approved by a majority of the disinterested directors of the Company but shall not include a transaction in which the company is
primarily issuing Common Stock or Common Stock Equivalents primarily for the purpose of raising capital or to a person or an entity
whose primary business is investing in securities; (v) shares of Common Stock, options or convertible securities issued in connection
with the provision of goods or services pursuant to transactions approved by a majority of the disinterested directors of the Company
but shall not include a transaction in which the company is issuing Common Stock or Common Stock Equivalents primarily for the
purpose of raising capital or to a person or an entity whose primary business is investing in securities; and (vi) shares
of Common Stock, options or convertible securities issued in connection with sponsored research, collaboration, technology license,
development, investor or public relations, marketing or other similar agreements or strategic partnerships approved by a majority
of the disinterested directors of the Company but shall not include a transaction in which the Company is primarily issuing Common
Stock or Common Stock Equivalents primarily for the purpose of raising capital or to a person or an entity whose primary business
is investing in securities.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Registration Statement”
means the Company’s registration statement on Form S-1, as amended (File No.333-264372).

  

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Subsidiary”
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.

 

“Trading Day” means a day on which
the Common Stock is traded on a Trading Market.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York
Stock Exchange, or OTCQB or OTCQX (or any successors to any of the foregoing).

 

“Transfer Agent”
means Vstock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place, Woodmere, NY 11598
and a facsimile number of, and any successor transfer agent of the Company.

 

    	 	 	2/16

     

    

 

“Underwriting
Agreement” means the underwriting agreement, dated as of [___], 2023, among the Company and Maxim Group, LLC, as representative
of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its terms.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.

 

“Warrant Agency
Agreement” means that certain warrant agency agreement, dated on or about the Initial Exercise Date, between the Company and
the Warrant Agent.

 

“Warrant Agent” means the Transfer
Agent and any successor warrant agent of the Company.

 

“Warrants”
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.

 

Section 2. Exercise.

 

a) Exercise of Warrant.
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business
Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the
provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

Notwithstanding the foregoing in this Section
2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this Warrant held in book-entry
form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this
Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying
with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder’s
right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence
shall not apply.

 

    	 	 	3/16

     

    

 

b) Exercise Price.
The exercise price per Warrant Share under this Warrant shall be $[___]1, subject to adjustment hereunder (the “Exercise
Price”), provided that in no case shall the exercise price be less than the par value of the Common Stock. The Holder shall
not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for
any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date.

 

c) Cashless Exercise.
If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not
available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such
time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to
the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(68) of
Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the
principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of the Holder’s execution
of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day
and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours”
on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such
Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the
close of “regular trading hours” on such Trading Day;

 

(B) = the Exercise Price of this Warrant, as adjusted hereunder;
and

 

(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.

 

Notwithstanding anything herein to the contrary,
but without limiting the rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to this Section 2(c)
or to receive cash payments pursuant to Section 3(d)(i) and Section 3(d)(iv) herein, the Company shall not be required to make any cash
payments or net cash settlement to the Holder in lieu of delivery of the Warrant Shares. If Warrant Shares are issued in such a cashless
exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take
on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section
2(c).

 

d) Mechanics of Exercise.

 

i. Delivery of Warrant
Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through
its Deposit and Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder
or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company’s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price
to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the
Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of
Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason
to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay
to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based
on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading
Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period”
means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any
Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at
any time after the time of execution of the Underwriting Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s)
by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date
for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received
by such Warrant Share Delivery Date.

  

 

1 110% of the initial public offering price of the Unit.

 

    	 	 	4/16

     

    

 

ii. Delivery of New
Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon
surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.

 

iii. Rescission Rights.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv. Compensation for
Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the
Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i)
above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
“Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Warrant
Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrant Shares with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver Warrant Shares upon exercise of the
Warrant as required pursuant to the terms hereof.

 

v. No Fractional Shares
or Scrip. No fractional Warrant Shares or scrip representing fractional Warrant Shares shall be issued upon the exercise of this Warrant.
As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole Warrant Share.

 

vi. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that, in
the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto,
the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees
required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vii. Closing of
Books. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

 

    	 	 	5/16

     

    

 

e) Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the
number of Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder
that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the
Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained
in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within
one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to
the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the issuance
of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the
number of shares of Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this Warrant
held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply
to a successor holder of this Warrant.

 

Section 3. Certain Adjustments.

 

a) Stock Dividends
and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance
of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares
of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common
Stock into a smaller number of shares, or (iv) issues by reclassification of Common Stock any shares of capital stock of the Company,
then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common
Stock and such other capital stock of the Company (excluding treasury shares, if any) outstanding immediately before such event and of
which the denominator shall be the number of shares of Common Stock and such other capital stock of the Company (excluding treasury shares,
if any) outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

    	 	 	6/16

     

    

 

b) Subsequent Equity
Sales. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell, enter into
an agreement to sell, or grant any option to purchase, or sell, enter into an agreement to sell, or grant any right to reprice, or otherwise
dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock
Equivalents, at an effective price per share less than the Exercise Price then in effect (such lower price, the “Base Share Price”
and such issuances collectively, a “Dilutive Issuance”) (it being understood and agreed that if the holder of the Common
Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating
conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with
such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such
issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective price),
then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall be reduced
and only reduced to equal the Base Share Price provided that the Base Share Price shall not be less than $[5.00] (subject to adjustment
for reverse and forward stock splits, recapitalizations and similar transactions following the Initial Issuance Date). Notwithstanding
the foregoing, no adjustments shall be made, paid or issued under this Section 3(b) in respect of an Exempt Issuance. The Company shall
notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any shares of Common Stock or
Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance price, or applicable reset price, exchange
price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”). For purposes of clarification,
whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 3(b), upon the occurrence of any Dilutive Issuance,
the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price regardless of whether the Holder accurately
refers to the Base Share Price in the Notice of Exercise.

 

c) Subsequent Rights
Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common
Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common
Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such
Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common
Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue
or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase
Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in
such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such
extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

d) [RESERVED].

 

    	 	 	7/16

     

    

 

e) Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries,
taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition
of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer,
tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged
for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates
a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires
more than 50% of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company
(not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated
with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental
Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each
Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction,
at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares
of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder
of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate
Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of
a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date
of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the
date of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction
is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled
to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the
Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of
the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination
thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in
connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have
received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such
Fundamental Transaction. “Black Scholes Value” means the value of this Warrant based on the Black-Scholes Option
Pricing Model obtained from the “OV” function on Bloomberg determined as of the day of consummation of the applicable
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate
for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction
and the Termination Date, (B) an expected volatility equal to the greater of the 30 day, 100
day and 365 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction,
(C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered
in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the
highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated
Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day
of the Holder’s request pursuant to this Section 3(d) and (D) a remaining option time equal to the time between the date
of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost
of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration)
within the later of (i) five Business Days of the Holder’s election and (ii) the date of consummation of the Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such
Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this
Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such
number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the
obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.

 

f) Calculations.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

    	 	 	8/16

     

    

 

g) Notice to Holder.

 

i. Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice to Allow
Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock are converted into other
securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of
the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last
facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of
the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)
the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of Common
Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing
on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

h) Voluntary Adjustment
by Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant,
subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period of time deemed
appropriate by the board of directors of the Company.

 

Section 4. Transfer of Warrant.

 

a) Transferability.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.

 

b) New Warrants.
If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined with other
Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations
in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to
any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges
shall be dated the Initial Issuance Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares
issuable pursuant thereto.

 

    	 	 	9/16

     

    

 

c) Warrant Register.
The Warrant Agent and/or the Company (with regard to any portion of the Warrant in certificated form issued pursuant to the terms of the
Warrant Agency Agreement) shall register this Warrant, upon records to be maintained by the Warrant Agent and/or the Company for that
purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company and
the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise
hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 5. Miscellaneous.

 

a) No Rights
as Shareholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to Section
2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to
net cash settle an exercise of this Warrant.

 

b) Loss, Theft, Destruction
or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft
or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c) Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken, or such right may be exercised on the next succeeding Business Day.

 

d) Authorized Shares.

 

(i) The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).

 

(ii) Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its articles
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of the Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing,
the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be necessary to enable the Company to perform its obligations under this Warrant.

 

(iii) Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.

 

    	 	 	10/16

     

    

 

e) Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

f) Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) Nonwaiver and Expenses.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company
shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices.

 

Any and all notices or other communications
or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered
personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service, addressed to the Company, at 1420 Celebration
Blvd., 2nd Floor, Celebration, FL 34747, Attention: Joseph La Rosa, Chief Executive Officer, email address: joe@larosarealtycorp.com,
or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and
all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number,
e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder
shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via
facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time)
on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the
facsimile number or via e- mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30
p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non- public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.

 

i) Limitation of Liability.
No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of
any Warrant Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

j) Remedies. The
Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.

 

    	 	 	11/16

     

    

 

k) Successors and
Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.

 

l) Amendment.
This Warrant may be modified or amended, or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder or the beneficial owner of this Warrant, on the other hand.

 

m) Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings. The
headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

o) Warrant Agency
Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject to the
Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement,
the provisions of this Warrant shall govern and be controlling.

 

********************

(Signature Page Follows)

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	 	
    LA ROSA HOLDINGS CORP.

     

	 	By: 	          
	 	Joseph La Rosa
	 	Chief Executive Officer

 

    	 	 	12/16

     

    

 

EXHIBIT A

 

NOTICE OF EXERCISE

 

TO: LA ROSA HOLDINGS CORP.

 

(1) The undersigned hereby elects to purchase Warrant Shares of the Company
pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full,
together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

 ̈
in lawful money of the United States; or

 

 ̈
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).

 

(3) Please issue said Warrant Shares in the name of the undersigned or
in such other name as is specified below:

 

	 	 

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

 

	 	 
	 	 
	 	 

 

[SIGNATURE OF HOLDER]

 

	Name of Investing Entity: 	 
	 	 
	Signature of Authorized Signatory of Investing Entity:	 
	 	 
	Name of Authorized Signatory: 	 
	 	 
	Title of Authorized Signatory:	 
	 	 
	Date: 	 

 

    	 	 	13/16

     

    

 

EXHIBIT B

 

ASSIGNMENT

 

FORM

 

(To assign the foregoing Warrant, execute this form and supply required
information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby
are hereby assigned to

 

	Name:	(Please Print)
	 	 
	Address:	(Please Print)
	 	 
	Phone Number	 
	Email Address	 
	 	 
	Dated: ___________, ___________	 
	Holder’s Signature:	 
	Holder’s Address:	 

 

    	 	 	14/16

     

    

 

EXHIBIT 2

 

Form of Warrant Certificate Request Notice

 

WARRANT CERTIFICATE REQUEST NOTICE

 

To: Vstock Transfer, LLC, as Warrant Agent for La Rosa Holdings Corp. (the
“Company”)

 

The undersigned Holder of Common Stock Purchase Warrants (“Warrants”)
in the form of Global Warrants issued by the Company hereby elects to receive a Warrant Certificate evidencing the Warrants held by the
Holder as specified below:

 

	1.	Name of Holder of Warrants in form of Global Warrants:	 
	 	 	 
	2.	Name of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global Warrants):	 
	 	 	 
	 	 	 
	3.	Number of Warrants in name of Holder in form of Global Warrants:	 
	 	 	 
	4.	Number of Warrants for which Warrant Certificate shall be issued:	 
	 	 	 
	5.	Number of Warrants in name of Holder in form of Global Warrants after issuance of Warrant Certificate, if any:	 
	 	 	 
	6.	Warrant Certificate shall be delivered to the following address:	 

 

	 	 
	 	 
	 	 
	 	 

 

The undersigned hereby acknowledges and agrees that,
in connection with this Warrant Exchange and the issuance of the Warrant Certificate, the Holder is deemed to have surrendered the number
of Warrants in form of Global Warrants in the name of the Holder equal to the number of Warrants evidenced by the Warrant Certificate.

 

[SIGNATURE OF HOLDER]

 

	Name of Investing Entity: 	 
	 	 
	Signature of Authorized Signatory of Investing Entity:	 
	 	 
	Name of Authorized Signatory: 	 
	 	 
	Title of Authorized Signatory:	 
	 	 
	Date: 	 

 

    	 	 	15/16

     

    

 

EXHIBIT 3

 

Form of Global Warrants Request Notice

 

GLOBAL WARRANTS REQUEST NOTICE

 

To: Vstock Transfer, LLC, as Warrant Agent for La Rosa Holdings Corp. (the
“Company”)

 

The undersigned Holder of Common Stock Purchase Warrants (“Warrants”)
in the form of Warrants Certificates issued by the Company hereby elects to receive a Global Warrant evidencing the Warrants held by the
Holder as specified below:

 

	1.	Name of Holder of Warrants in form of Warrant Certificates:	 
	 	 	 
	2.	Name of Holder in Global Warrant (if different from name of Holder of Warrants in form of  Warrant Certificates):	 
	 	 	 
	3.	Number of Warrants in name of Holder in form of Warrant Certificates:	 
	 	 	 
	4.	Number of Warrants for which Global Warrant shall be issued:	 
	 	 	 
	5.	Number of Warrants in name of Holder in form of Warrant Certificates after issuance of Global Warrant, if any:	 
	 	 	 
	6.	Global Warrant shall be delivered to the following address:	 

 

	 	 
	 	 
	 	 
	 	 

 

The undersigned hereby acknowledges and agrees that,
in connection with this Global Warrant Exchange and the issuance of the Global Warrant, the Holder is deemed to have surrendered the number
of Warrants in form of Warrant Certificates in the name of the Holder equal to the number of Warrants evidenced by the Global Warrant.

 

[SIGNATURE OF HOLDER]

 

	Name of Investing Entity: 	 
	 	 
	Signature of Authorized Signatory of Investing Entity:	 
	 	 
	Name of Authorized Signatory: 	 
	 	 
	Title of Authorized Signatory:	 
	 	 
	Date: 	 

 

    	 	 	16/16Exhibit 10.95 

 

THIS NOTE HAS BEEN ISSUED WITH “ORIGINAL
ISSUE DISCOUNT” FOR U.S. FEDERAL INCOME TAX PURPOSES. THE ISSUER WILL MAKE AVAILABLE TO ANY HOLDER OF THIS NOTE: (1) THE ISSUE PRICE
AND ISSUE DATE OF THE NOTE, (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE NOTE, (3) THE YIELD TO MATURITY OF THE NOTE, AND (4) ANY
OTHER INFORMATION REQUIRED TO BE MADE AVAILABLE BY U.S. TREASURY REGULATIONS UPON RECEIVING A WRITTEN OR ELECTRONIC REQUEST FOR SUCH INFORMATION.

 

NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES
REPRESENTED BY THIS PROMISSORY NOTE NOR THE SECURITIES INTO WHICH THIS PROMISSORY NOTE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES REPRESENTED BY THIS PROMISSORY NOTE MAY NOT BE OFFERED FOR
SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER AND REASONABLY ACCEPTABLE TO THE
ISSUER), IN A FORM ACCEPTABLE TO THE ISSUER, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT, OR (II) UNLESS SOLD PURSUANT TO RULE 144
OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

	Issue Date: December 2, 2022	 	Purchase Price:	 	$	449,500.00	 
	Maturity Date: As set forth below.	 	Original Issue Discount:	 	$	42,030.00	 
	Original Interest Discount Per Annum:  _____107.78%	 	Original Principal 
Amount:	 	$	491,530.00	 

 

CONVERTIBLE ORIGINAL ISSUE DISCOUNT
PROMISSORY NOTE

 

For value received,
La Rosa Holdings Corp., a corporation organized under the laws of the State of Nevada (“La Rosa” or the “Borrower”),
hereby promises to pay to the order of Joseph La Rosa or his assigns (the “Holder”) the principal sum of Four Hundred
Ninety One Thousand Five Hundred and Thirty Dollars and No Cents ($491,530.00) (the “Original Principal Amount”) on
the Maturity Date set forth below or upon acceleration or otherwise, as set forth herein in this Convertible Original Issue Discount Promissory
Note or as it may be amended, extended, renewed and refinanced (this “Note”). The “Original Interest Discount”
shall be one hundred and seven and eight hundred seventy eight one hundredths percent (107.78%) per annum (“Original Interest
Discount Rate”) if calculated for a one year term. Each of Borrower and Holder are a “party” to this Note
and together, they are the “parties” hereto.

 

The Holder paid to the
Borrower the purchase price of Four Hundred Forty NineThousand Five Hundred Dollars and No Cents ($449,500.00) (“Purchase Price”)
on the Issue Date of this Note.

 

    	 	1	 

     

    

 

The maturity date of
this Note (“Maturity Date”) shall be the earlier of: (i) six (6) months from the Issue Date, or (ii) on the date of
the consummation of the Borrower’s initial public offering of Units (“IPO”), with each Unit consisting of one
share of common stock, $0.0001 par value per share (the “Common Stock”), and one warrant to purchase one share of Common
Stock, pursuant to its registration statement, as amended (File No. 333-264372), as filed with the Securities and Exchange Commission
(“SEC”). The principal sum, as well as interest and other fees shall be due and payable in accordance with the payment
terms set forth herein.

 

Subject to Section 5.9
below, this Note may not be prepaid in whole or in part except as otherwise explicitly set forth herein.

 

Any amount of principal,
interest, other amounts due hereunder which is not paid by the due date as specified herein, shall bear interest at the lesser of: (i)
the rate of twenty four percent (24%) per annum, or (ii) the maximum legal amount permitted by the laws of the State of Nevada (“Default
Interest Rate”), from the due date thereof until the same is paid in full, or on the date that the parties have reinstated the
Note under its original or other terms, including following the entry of a judgment in favor of Holder (“Default Interest”).

 

If any payment (other
than a payment due at maturity or upon default) is not made on or before its due date, Holder may at its discretion charge and Borrower
shall pay to Holder a delinquency penalty equal to Five Thousand Dollars and No Cents ($5,000.00) per month. The unpaid balances on all
obligations payable by Borrower and due to Holder pursuant to the terms of this Note, shall in addition to other remedies contained herein,
bear interest after default or maturity at an annual rate equal to the Default Interest Rate.

 

Except as provided for
in Section 1.2 below, all payments of principal and interest due hereunder (to the extent not converted into Borrower’s Common Stock)
shall be paid by automatic debit, wire transfer, check or in coin or currency which, at the time or times of payment, is the legal tender
for public and private debts in the United States of America and shall be made at such place as Holder may from time to time appoint in
a payment invoice or otherwise in writing, and in the absence of such appointment, then at the offices of Holder at such address as the
Holder shall hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Unless otherwise agreed
or required by applicable law, payments will be applied first to any accrued unpaid interest, then to any late charges, and then to principal.
Whenever any amount expressed to be due by the terms of this Note is due on any day which is not a Business Day, the same shall instead
be due on the next succeeding day which is a Business Day and, in the case of any interest payment date which is not the date on which
this Note is paid in full, interest shall continue to accrue during such extension. As used in this Note, the term “Business
Day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the city of New York, New York are
authorized or required by law or executive order to remain closed.

 

It is further acknowledged
and agreed that the Principal Amount owed by Borrower under this Note shall be increased by the amount of all reasonable expenses incurred
by the Holder in connection with the collection of amounts due, or enforcement of any terms pursuant to, this Note. All such expenses
shall be deemed added to the Principal Amount hereunder to the extent such expenses are paid or incurred by the Holder and shall earn
interest at the Original Interest Discount Rate set forth above.

 

    	 	2	 

     

    

 

This Note shall be an
unsecured obligation of the Borrower, junior in priority to any senior debt and pari passu with all current and future Indebtedness
except for any bank loans of the Borrower and any subsidiaries, whether such subsidiaries exist on the Issue Date or are created or acquired
thereafter (each a “Subsidiary” and collectively, the “Subsidiaries”). As used herein, the term
“Indebtedness” means (a) all indebtedness of Borrower for borrowed money or for the deferred purchase price of property
or services, including any type of letters of credit, but not including deferred purchase price obligations in place as of the Issue Date
or obligations to trade creditors incurred in the common course of business, (b) all obligations of the Borrower evidenced by notes, bonds,
debentures or other similar instruments, (c) purchase money indebtedness hereafter incurred by the Borrower to finance the purchase of
fixed or capital assets, including all capital lease obligations of the Borrower which do not exceed the purchase price of the assets
funded, (d) all guarantee obligations of the Borrower in respect of obligations of the kind referred to in clauses (a) through (c) above
that the Borrower would not be permitted to incur or enter into, and (e) all obligations of the kind referred to in clauses (a) through
(d) above that the Borrower is not permitted to incur or enter into that are secured and/or unsecured by (or for which the holder of such
obligation has an existing right, contingent or otherwise, to be secured and/or unsecured by) any lien or encumbrance on property (including
accounts and contract rights) owned by the Borrower, whether or not the Borrower has assumed or become liable for the payment of such
obligation.

 

This Note is free from
all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar
rights of shareholders of Borrower.

 

In addition to the terms above, the following
terms shall also apply to this Note:

 

ARTICLE I. PAYMENTS

 

1.1       Principal
Payments. The Original Principal Amount shall be due and payable on the Maturity Date.

 

1.2       Interest
Payments. Interest on this Note (i) is payable at maturity; and (ii) is guaranteed to the Holder for the entire term of the
Note, without regard to an acceleration of the Maturity Date, based on the total Original Principal Amount, without regard to a reduction
of the Original Principal Amount resulting from, without limitation, principal payments, Conversion (as defined below), or prepayment
by Borrower.

 

1.3       Other
Payment Obligations. All payments, fees, penalties, and other charges, if any, due under this Note shall be payable pursuant to the
terms contained herein, but in any case, shall be payable no later than the Maturity Date.

 

    	 	3	 

     

    

 

ARTICLE II. CONVERSION RIGHTS

 

2.1       Conversion
Right. The Holder shall have the right at any time, at the Holder’s option to convert all or any part of the outstanding and
unpaid Original Principal Amount into fully paid and non-assessable shares of Common Stock of Borrower or other securities into which
such Common Stock shall hereafter be changed or reclassified (each, a “Conversion Share”) at the conversion price (the
“Conversion Price”) determined as provided herein (a “Conversion”). The number of shares
of Common Stock to be issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below)
by the applicable Conversion Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit
A (the “Notice of Conversion”), delivered to Borrower by the Holder in accordance with Section 2.4 below; provided
that the Notice of Conversion is submitted by facsimile or e-mail (or by other means resulting in, or reasonably expected to result in,
notice) to Borrower before 6:00 p.m., New York, New York time on such conversion date (the “Conversion Date”). The
term “Conversion Amount” means, with respect to any conversion of this Note, the sum of: (1) the portion or all of
the Original Principal Amount of this Note to be converted in such conversion; plus (2) at the Holder’s option, accrued and
unpaid Default Interest, if any; plus (3) the Holder’s expenses relating to a Conversion, including but not limited to amounts
paid by Holder on the Borrower’s transfer agent account; plus (4) at the Holder’s option, any amounts owed to the Holder
pursuant to Section 2.4(g) hereof.

 

 2.2       Conversion Price.

 

(a)       Calculation
of Conversion Price. The Conversion Price shall be a discount of twenty-five percent (25%) to the price per Unit in the Borrower’s
IPO (“Fixed Conversion Price”).

 

 (b)        Fixed Conversion Price Adjustments.

 

(1)       Common
Stock Distributions and Splits. If Borrower, at any time while this Note is outstanding: (i) pays a distribution on its Common Stock
or otherwise makes a distribution or distributions payable in Common Stock on its Common Stock; (ii) subdivides outstanding shares of
its Common Stock into a larger (or smaller) number of shares; or (iii) issues, in the event of a reclassification of shares of Common
Stock, any Common Stock of Borrower, then the Fixed Conversion Price shall be revised to be the product of: (x) the Fixed Conversion Price
multiplied by (y) a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of Borrower)
outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock to be outstanding
immediately after such event.

 

(2)       Fundamental
Transaction. If, at any time while this Note is outstanding, (i) Borrower effects any merger or consolidation of Borrower with or
into another person or entity (“Person”), (ii) Borrower effects any sale of all or substantially all of its assets
in one transaction or a series of related transactions, (iii) any tender offer or exchange offer (whether by Borrower or another Person)
is completed pursuant to which holders of the Common Stock are permitted to tender or exchange their shares for other securities, cash
or property, or (iv) Borrower effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities, cash or property (in any such case, a “Fundamental
Transaction”), then, upon any subsequent conversion of this Note, Holder shall have the right to receive, for each Conversion
Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the same
kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction
if it had been, immediately prior to such Fundamental Transaction, the holder of one share of Common Stock (the “Alternate Consideration”).
For purposes of any such conversion, the determination of the Fixed Conversion Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and Borrower shall apportion the Fixed Conversion Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.

 

    	 	4	 

     

    

 

 

(3)       Anti-dilution
Adjustment. If at any time while this Note is outstanding, Borrower sells, grants, or otherwise makes a disposition of Common
Stock, or sells, grants, or otherwise makes a disposition of other securities (or in the case of securities existing on the Issue
Date, amends such securities) convertible into, exercisable for, or that would otherwise entitle any Person the right to acquire
Common Stock, or announces its intention, or files any document with the SEC or other regulatory body that reflects its intention to
do of any of the foregoing, at an effective price per share that is lower than the then Fixed Conversion Price (such lower price,
the “Base Conversion Price” and such issuances, collectively, a “Dilutive Issuance”) (it being
agreed that if the holder of the Common Stock or other securities so issued shall at any time, whether by operation of purchase
price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or
rights per share which are issued in connection with such issuance, be entitled to receive Common Stock at an effective price per
share that is lower than the Fixed Conversion Price, such issuance shall be deemed to have occurred for less than the Fixed
Conversion Price on such date of the Dilutive Issuance, and the Base Conversion Price shall then be adjusted to equal the
lowest of such issuance price), then the Fixed Conversion Price shall be reduced to a price equal the Base Conversion Price as it
may be adjusted as provided for above. Such adjustment shall be made whenever such Common Stock or other securities are issued.
Notwithstanding the foregoing, no adjustment will be made under this Section 2.2(b)(3) in respect of an Exempt Issuance. For
purposes of this Section 2.2(b)(3) an “Exempt Issuance” means an issuance of Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock (i) upon the exercise or
exchange of any securities issued hereunder or under the Warrants (as defined in Section 3.1), (ii) to employees, directors of
Borrower pursuant to any stock or option or similar equity incentive plan duly adopted for such purpose by the Board of Directors of
Borrower, (iii) to banks, equipment lessors or other financial institutions, or to real property lessors, at market value as of the
date of issuance, pursuant to a debt financing, equipment leasing, or real property leasing transaction approved by the Board of
Directors of Borrower, (iv) to suppliers, consultants, or third party service providers in connection with the provision of goods or
services, at market value as of the date of issuance, pursuant to a stock option plan, agreement, or arrangement of the Borrower,
duly adopted for such purpose by the Board of Directors of Borrower, (v) pursuant to the acquisition of another corporation or other
entity by Borrower by merger, purchase of substantially all of the assets or other reorganization or pursuant to a joint venture
agreement, provided that such issuances are approved by the Board of Directors of Borrower, (vi) to third parties in connection with
collaboration, technology license, development, marketing or other similar agreements or strategic partnerships, in each case only
in connection with the operating business of the Borrower and approved by the Board of Directors of Borrower, or (vii) shares with
respect to which Holder waives its anti-dilution rights granted hereby; provided, however, that any such issuance described in (v)
and (vi) shall only be to a Person (or to the equity holders of a person) which is, itself or through its subsidiaries, an operating
company or an owner of an asset (or an employee, director, consultant, or advisor thereof), in a business synergistic with the
business of Borrower and shall provide to Borrower additional benefits in addition to the investment of funds, but in none of (ii)
through (vi) above shall include a transaction in which Borrower is issuing securities primarily for the purpose of raising capital
or to a recipient whose primary business is investing in securities or to a recipient whose primary business is investor relations
or public relations. In the event of an issuance of securities involving multiple tranches or closings, any adjustment pursuant to
this Section 2.2(b)(3) shall be calculated as if all such securities were issued upon distribution of the initial
tranche.

 

    	 	5	 

     

    

 

(4)       Notice
to the Holder. Whenever the Fixed Conversion Price is adjusted pursuant to any provision of this Section 2.2(b), Borrower shall, within
two (2) Business Days, deliver to Holder a notice setting forth the Fixed Conversion Price after such adjustment and setting forth a brief
statement of the facts requiring such adjustment, provided that Borrower’s failure to timely provide the notice shall not affect
the automatic adjustments contemplated hereby.

 

2.3       Authorized
Shares. Borrower covenants that during the period the conversion right exists, Borrower will reserve from its authorized and unissued
Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion
of this Note and exercise of the Warrants. Borrower is required at all times to have authorized and reserved seven (7) times the number
of shares that is actually issuable upon full conversion of this Note (based on the Fixed Conversion Price of the Note in effect from
time to time, which, if cannot be determined shall be estimated in good faith by Borrower) it being acknowledged and agreed by the parties
that for the initial issuance of the Note, 100,000 shares of Common Stock is sufficient and will be reserved (the “Reserved
Amount”). The Reserved Amount shall be increased from time to time in accordance with Borrower’s obligations hereunder.
Borrower represents that upon issuance, such shares will be duly authorized and validly issued, fully paid and non-assessable. In addition,
if Borrower shall issue any securities or make any change to its capital structure which would change the number of shares of Common Stock
into which the Note shall be convertible at the then current Conversion Price, Borrower shall at the same time make proper provision so
that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive rights, for
conversion of the outstanding Note, including but not limited to authorizing additional shares or
effectuating a reverse split. Borrower (i) acknowledges that to will irrevocably instruct its transfer agent by letter to issue
certificates for the Common Stock issuable upon conversion of this Note and exercise of the Warrants, and (ii) agrees that its issuance
of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing Common Stockcertificates
to execute and issue the necessary certificates for shares of Common Stock in accordance with the terms and conditions of this Note. If,
at any time Borrower does not maintain the Reserved Amount it will be considered an Event of Default under Section

4.1.2 of the Note.

 

 2.4       Method of Conversion.

 

(a)       Mechanics
of Conversion. Subject to Section 2.1, this Note may be converted by the Holder in whole or in part, at any time from the date hereof,
by (A) submitting to Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the
prior to 6:00 p.m., New York, New York time on the Conversion Date, and if after 6:00 p.m., the Conversion Date shall be the next Business
Day) and (B) subject to Section 2.4(b), surrendering this Note at the principal office of Borrower.

 

(b)       Surrender
of Note Upon Conversion. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in accordance with
the terms hereof, Holder shall not be required to physically surrender this Note to Borrower unless the entire unpaid Original Principal
Amount of this Note is so converted. Holder and Borrower shall maintain records showing the Original Principal Amount so converted and
the dates of such conversions or shall use such other method, reasonably satisfactory to Holder and Borrower, so as not to require physical
surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such records of Borrower shall, prima
facie, be controlling and determinative in the absence of manifest error. Holder and any assignee, by acceptance of this Note, acknowledges
and agrees that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted
Original Principal Amount of this Note represented by this Note may be less than the amount stated on the face hereof.

 

    	 	6	 

     

    

 

 

(c)       Payment
of Taxes. Borrower shall not be required to pay any tax which may be payable in respect of any transfer involved in the issue and
delivery of shares of Common Stock or other securities or property on conversion of this Note in a name other than that of the Holder
(or in street name), and Borrower shall not be required to issue or deliver any such shares or other securities or property unless and
until the Person or Persons (other than the Holder or the custodian in whose street name such shares are to be held for the Holder’s
account) requesting the issuance thereof shall have paid to Borrower the amount of any such tax or shall have established to the satisfaction
of Borrower that such tax has been paid.

 

(d)       Delivery
of Common Stock Upon Conversion. Upon receipt by Borrower from Holder of an e-mail (or other reasonable means of communication) of
a Notice of Conversion meeting the requirements for conversion as provided in this Section 2.4, Borrower shall issue and deliver to or
cause to be issued and delivered to or upon the order of Holder certificates for the shares of Common Stock issuable upon such conversion
by the end of the next Business Day after such receipt (the “Deadline”) (and, solely in the case of conversion of the
entire unpaid Original Principal Amount hereof, surrender of this Note) in accordance with the terms hereof.

 

(e)       Obligation
of Borrower to Deliver Common Stock. Upon receipt by Borrower of a Notice of Conversion, Holder shall be deemed to be the holder of
record of the shares of Common Stock issuable upon such conversion, the outstanding Original Principal Amount and the amount of the Original
Principal Amount of this Note shall be reduced to reflect such conversion, and, unless Borrower defaults on its obligations under this
Article II, all rights with respect to the portion of this Note being so converted shall forthwith terminate except the right to receive
the Common Stock or other securities, cash or other assets, as herein provided, on such conversion. If Holder shall have given a Notice
of Conversion as provided herein, Borrower’s obligation to issue and deliver the certificates for the Common Stock shall be absolute
and unconditional, irrespective of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to
any provision thereof, the recovery of any judgment against any person or any action to enforce the same, any failure or delay in the
enforcement of any other obligation of Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination,
or any breach or alleged breach by the Holder of any obligation to Borrower, and irrespective of any other circumstance which might otherwise
limit such obligation of Borrower to Holder in connection with such conversion. The Conversion Date specified in the Notice of Conversion
shall be the Conversion Date so long as the Notice of Conversion is received by Borrower before 6:00 p.m., New York, New York time, on
such date, and if received after 6:00 p.m., the Conversion Date shall be the next Business Day.

 

    	 	7	 

     

    

 

(f)       Delivery
of Common Stock by Electronic Transfer. If the shares of the Borrower are publicly traded, in lieu of delivering physical certificates
representing the Common Stock issuable upon conversion, provided Borrower is participating in the Depository Trust Company (“DTC”)
Fast Automated Securities Transfer (“FAST”) program, upon request of Holder and its compliance with the provisions
contained in Section 2.1 and in this Section 2.4, Borrower shall use its best efforts to cause its transfer agent to electronically transmit
the Common Stock issuable upon conversion to Holder by crediting the account of Holder’s broker with DTC through its Deposit Withdrawal
Agent Commission (“DWAC”) system. If the Borrower is not registered with DTC as of the Issue Date, the Borrower shall
be required to register with DTC prior to the consummation of the IPO, and the provisions of this paragraph shall apply after such registration.
Failure to become DTC registered or maintain DTC eligibility as provided herein shall be an Event of Default under Section 4.1.22 of this
Note.

 

(g)       Failure
to Deliver Common Stock Prior to Deadline. Without in any way limiting Holder’s right to pursue other remedies, including actual
damages and/or equitable relief, the parties agree that if Borrower causes the Common Stock issuable upon conversion of this Note to not
be delivered by the second (2nd) Trading Day following the Deadline (such non- delivery referred to herein as a “Conversion Default”),
Borrower shall pay to the Holder One Thousand Dollars and No Cents ($1,000.00) per day in cash, for each day beyond the Deadline that
Borrower fails to deliver such shares of Common Stock (“Conversion Default Payment”). For purposes of this Note,
the term “Trading Day” means any day that the Borrower’s Common Stock is listed for trading or quotation on the
Nasdaq Capital Market, the Over-The-Counter market, or any other exchanges or electronic quotation systems on which the Common Stock is
then traded.

 

(h)       Such
cash amount shall be paid to Holder by the fifth day of the month following the month in which it has accrued or, at the option
of the Holder (by written notice to Borrower by the first day of the month following the month in which it has accrued), shall be added
to the Original Principal Amount of this Note, in which event interest shall accrue at the Original Interest Discount Rate thereon in
accordance with the terms of this Note and such additional Original Principal Amount shall be convertible into share of Common Stock in
accordance with the terms of this Note. Borrower agrees that the right to convert is a valuable right to Holder, and as such, Borrower
will not take any actions to hamper, delay or prevent any Holder conversion of the Note. The damages resulting from a failure, attempt
to frustrate, interference with such conversion right are difficult if not impossible to qualify. Accordingly, the parties acknowledge
that the liquidated damages provision contained in this Section 2.4(g) are justified.

 

2.5       Concerning
the Common Stock. The Common Stock issuable upon conversion of this Note may not be sold or transferred unless (i) such shares are
sold pursuant to an effective registration statement under the Securities Act of 1933, as amended (“Securities Act”)
or (ii) Borrower or its transfer agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance
and scope customary for opinions of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be
sold or transferred pursuant to an exemption from such registration, or (iii) such shares may be sold or transferred pursuant to Rule
144 under the Act (or a successor rule) (“Rule 144”), or (iv) such shares are transferred to an “affiliate”
(as defined in Rule 144) of Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 2.5 and
who is an Accredited Investor. Except as otherwise provided (and subject to the removal provisions set forth below), until such time as
the Common Stock issuable upon conversion of this Note have been registered under the Securities Act or otherwise may be sold pursuant
to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold, each certificate
for the Common Stock issuable upon conversion of this Note that has not been so included in an effective
registration statement or that has not been sold pursuant to an effective registration statement or an exemption that permits removal
of the legend, shall bear a legend substantially in the following form, as appropriate:

 

    	 	8	 

     

    

 

THE SALE OF THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES
MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER AND REASONABLY
ACCEPTABLE TO THE COMPANY), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT, OR (II) UNLESS SOLD PURSUANT
TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

The legend set forth above shall be removed
and Borrower shall issue to Holder a new certificate therefore free of any transfer legend if: (i) Borrower or its transfer agent shall
have received an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to the
effect that a public sale or transfer of such Common Stock may be made without registration under the Securities Act, which opinion shall
be accepted by Borrower (which acceptance shall be subject to and conditioned on any requirements, if any, of its transfer agent, the
exchange on which Borrower’s Common Stock is then trading or other applicable laws, rules or regulations) so that the sale or transfer
is effected, or (ii) in the case of the Common Stock issuable upon conversion of this Note, such security is registered for sale by Holder
under an effective registration statement filed under the Securities Act or otherwise may be sold pursuant to Rule 144 without any restriction
as to the number of securities as of a particular date that can then be immediately sold. In the event that Borrower does not accept the
opinion of counsel provided by Holder with respect to the transfer of the Common Stock pursuant to an exemption from registration, such
as Rule 144 or Regulation S, at the Deadline, it will be considered an Event of Default pursuant to Section 4.1.2 of the Note.

 

2.6       Status as
Shareholder. Upon submission of a Notice of Conversion by a Holder, (i) the shares covered
thereby shall be deemed converted into Common Stock, and (ii) Holder’s rights as a Holder of such converted portion of this
Note shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies
provided herein or otherwise available at law or in equity to such Holder because of a failure by Borrower to comply with the terms
of this Note. Notwithstanding the foregoing, if a Holder has not received certificates for all shares of Common Stock prior to the
tenth (10th) Business Day after the expiration of the Deadline with respect to a conversion of any portion of this Note for any
reason, then (unless Holder otherwise elects to retain its status as a holder of the shares of the Common Stock by so notifying
Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted portions of this Note and
Borrower shall, as soon as practicable, return such unconverted Note to the Holder or, if the Note has not been surrendered, adjust
its records to reflect that such portion of this Note has not been converted. In all cases, the Holder shall retain all of its
rights and remedies (including, without limitation, (i) the right to receive Conversion Default Payments pursuant to Section 2.4 to
the extent required thereby for such Conversion Default and any subsequent Conversion Default and (ii) the right to have the Fixed
Conversion Price with respect to subsequent conversions adjusted upon an Event of Default, if applicable) for Borrower’s
failure to convert this Note.

 

    	 	9	 

     

    

 

ARTICLE III.

RANKING, CERTAIN COVENANTS AND POST CLOSING OBLIGATIONS

 

3.1       Warrants.
Upon the payment of the Purchase Price by Holder to the Borrower, Borrower shall issue to Holder a warrant exercisable for 25,000 shares
of the Borrower’s Common Stock (the “Warrants”). The Warrants shall have the following terms: (1) a term of 60
Months; (2) full-ratchet anti-dilution protection provisions; and (3) an exercise price equal to the lower of:
(i) Ten Dollars and No Cents ($10.00) per share, or (ii) the price per share of any subsequent
offering undertaken by the Borrower. The Common Stock issuable upon the exercise of the Warrants are the “Warrant Shares”
herein.

 

3.2       Equity
Interest. Upon repayment of the loan, the, Borrower shall issue to Holder a number of shares of Common Stock equal to $300,000
(“Equity Interest”) valued on the price per share of any public (including the IPO) or private offering undertaken
by the Borrower. If no subsequent offering undertaken by the Borrower at the time of repayment then the Borrower shall issue the Holder
60,000 shares. The Common Stock issuable pursunat to this Section 3.3, the Warrant Shares and any shares of Common Stock converted pursuant
to this Note are referred to herein as the “Note Shares.”

 

 3.3       Distributions on Common Stock. [RESERVED.]

 

 3.4       Restrictions on Variable Rate Transactions. [RESERVED.]

 

 3.5       Restrictions on Other Certain Transactions. [RESERVED.]

 

3.6       Payments
from Future Funding Sources. Subject to the priority on payment of any senior debt, the Borrower shall pay to Holder on an accelerated
basis, any outstanding Original Principal Amount of the Note, along with all unpaid interest, and fees and penalties, if any, from the
sources of capital below, at the Holder’s discretion, it being acknowledged and agreed by Holder that Borrower shall have the right
to make bona fide payments to vendors with Common Stock:

 

3.6.1       Future
Financing Proceeds – one hundred percent (100%) of the net proceeds of any future financings by Borrower or any Subsidiary,
whether debt or equity (except from the IPO), or any other financing proceeds such as cash advances, royalties or earn-out payments provided,
however, that this provision is not applicable if the transaction generating the future financing proceeds has a specific use of proceeds
requirement that such proceeds are to be used exclusively to purchase the assets or equity of an unaffiliated business in an arm’s
length transaction and the proceeds are used accordingly.

 

3.6.2       Other
Future Receipts – one hundred percent (100%) of the net proceeds to the Borrower or Subsidiary resulting from the sale of any
assets of Borrower or any of its Subsidiaries including but not limited to, the sale of any Subsidiary,
the receipt in cash by Borrower or any of its Subsidiaries of any tax refunds, the sale of any tax credits, collections
by Borrower or any of its Subsidiaries pursuant to any settlement or judgement, but not including sales of inventory of the Borrower or
its Subsidiaries in the common course of business.

 

    	 	10	 

     

    

 

 

3.7       Use
of Proceeds. Borrower agrees to use the proceeds of this Note solely for the following purposes: (i) to pursue the IPO of the Units,
(ii) to pursue acquisitions, and (iii) for general working capital.

 

3.8       Ranking
and Security.. The obligations of the Borrower under this Note are unsecured by any assets of Borrower. This Note is junior to any
senior obligation of Borrower and pari passu with all general creditors of Borrower.

 

 3.9       Right of Participation. [RESERVED.]

 

 3.10     Registration Rights. [RESERVED.]

 

3.11     Rollover
Rights. So long as the Note is outstanding, if Borrower completes any single public offering or private placement of its equity, equity-linked
or debt securities (each, a “Future Transaction”), Holder may, in its sole discretion, elect to apply as purchase consideration
for such Future Transaction: (i) all, or any portion, of the then outstanding Original Principal Amount of the Note, including any amounts
that would be added to the principal outstanding in the event that any redemption right or prepayment right is exercised by either the
Holder or the Borrower, and (ii) any securities of the Borrower then held by the Holder, at their fair value (the “Rollover Rights”).
Borrower shall give written notice to Holder as soon as practicable, but in no event less than fifteen (15) days before the anticipated
closing date of such Future Transaction. Holder may exercise its Rollover Rights by providing the Borrower written notice of such exercise
within five (5) Business Days before the closing of the Future Transaction. In the event Holder exercises its Rollover Rights, then such
elected portion of the outstanding Original Principal Amount of this Note shall automatically convert into the corresponding securities
issued in such Future Transaction under the terms of such Future Transaction, such that the Holder will receive all securities (including,
without limitation, any warrants) issuable under the Future Transaction.

 

3.12     Exchange
Act Reporting. Upon the Borrower becoming an SEC reporting company subject to the requirements of the Securities Exchange Act of 1934,
as amended (“Exchange Act”), then thereafter, Borrower shall remain a fully reporting company under the SEC reporting
requirements and remain subject to and fully compliant with, the annual and periodic reporting requirements of the Exchange Act (including
but not limited to becoming current in its filings). Failure to remain a fully reporting company and subject to and compliant with the
Exchange Act as described herein, (including but not limited to becoming delinquent in its filings), shall be an Event of Default (as
defined below) under Section 4.1.9.

 

ARTICLE IV. EVENTS OF DEFAULT

 

4.1       It
shall be considered an event of default if any of the following events listed in this Article IV (each, an “Event of Default”)
shall occur:

 

4.1.1       Failure
to Pay Principal or Interest. Borrower fails to pay the principal hereof or interest
thereon when due on this Note, whether at maturity, upon acceleration or otherwise. A three (3) day cure period shall apply for failure
to make a payment when due except where payments are noted herein as being due immediately or for payments due on the Maturity Date which
in each case shall have no cure period.

 

    	 	11	 

     

    

 

4.1.2       Failure
to Reserve Shares. Borrower fails to reserve a sufficient amount of shares of Common Stock as required under the terms of this Note
(including the requirements of Section 2.3 of this Note), fails to issue Common Stock to Holder (or announces or threatens in writing
that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of Holder in accordance with the
terms of this Note, fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form) shares
of Common Stock issued to Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, Borrower directs
its transfer agent not to transfer or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically
or in certificated form) Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required
by this Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from
removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any Common Stock issued to Holder
upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written announcement, statement
or threat that it does not intend to honor the obligations described in this paragraph), or fails to supply an opinion letter specific
to the fact that Common Stock issued pursuant to conversion of the Note, as well as the Equity Interest and the shares issued pursuant
to the Warrant are exempt from registration requirements pursuant to Rule 144, and any such failure shall continue uncured (or any written
announcement, statement or threat not to honor its obligations shall not be rescinded in writing) for three (3) Business Days after the
Holder shall have delivered a Notice of Conversion. It is an obligation of Borrower to remain current in its obligations to its transfer
agent. It shall be an event of default of this Note, if a conversion of this Note is delayed, hindered or frustrated due to a balance
owed by Borrower to its transfer agent. If at the option of the Holder, Holder advances any funds to Borrower’s transfer agent in
order to process a conversion, such advanced funds shall be paid by Borrower to the Holder within five (5) Business Days of a demand from
Holder, either in cash or as an addition to the outstanding Principal Amount of the Note, and such choice of payment method is at the
discretion of Borrower.

 

4.1.3       Breach
of Covenants. Borrower, or the relevant related party, as the case may be, breaches any material covenant, post-closing obligation
or other material term or condition contained in this Note, or in the related Warrant, or any other ancillary documents executed in connection
therewith (together, the “Transaction Documents”) and breach continues for a period of ten (10) days.

 

4.1.4       Breach
of Representations and Warranties. Any representation or warranty of Borrower made herein or in any agreement, statement or certificate
given pursuant hereto or in connection herewith, shall be false or misleading in any material respect when made and the breach of which
has (or with the passage of time will have) an effect on the rights of Holder with respect to this Note and the other Transaction Documents.

 

4.1.5       Receiver
or Trustee. Borrower or any Subsidiary of Borrower shall make an assignment for the benefit of creditors, or apply for or consent
to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such a receiver or
trustee shall otherwise be appointed.

 

    	 	12	 

     

    

 

4.1.6       Judgments
or Settlements. (i) Any money judgment, writ or similar process shall be entered or filed against Borrower or any Subsidiary of Borrower
or any of its property or other assets for more than Twenty Five Thousand Dollars and No Cents ($25,000.00), and shall remain unvacated,
unbonded or unstayed for a period of twenty (20) days unless otherwise consented to by the Holder; or (ii) the settlement of any claim
or litigation, creating an obligation on the Borrower in amount over Twenty Five Thousand Dollars and No Cents ($25,000.00).

 

4.1.7       Bankruptcy.
Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary, for relief under any
bankruptcy law or any law for the relief of debtors shall be instituted by or against Borrower or any Subsidiary of Borrower. With respect
to any such proceedings that are involuntary, Borrower shall have a forty five (45) day cure period in which to have such involuntary
proceedings dismissed.

 

4.1.8       Delisting
of Common Stock. If at any time on or after the date in which Borrower’s Common Stock are listed or quoted on the OTC Pink or
an equivalent U.S. replacement exchange, the Nasdaq Global Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE
MKT (a “Listing Event”), Borrower shall fail to maintain the listing or quotation of the Common Stock, or if its shares
have been suspended from trading on the OTC Pink or a U.S. equivalent replacement exchange, the Nasdaq Global Market, the Nasdaq Capital
Market, the New York Stock Exchange, or the NYSE MKT.

 

4.1.9       Failure
to Comply with the Exchange Act. If at any time after Borrower becomes an SEC reporting company, Borrower shall fail to be fully compliant
with, or ceases to be subject to, the reporting requirements of the Exchange Act (including but not limited to becoming delinquent in
its filings).

 

4.1.10       Change
of Control or Liquidation. Any Change of Control of the Borrower, or the dissolution, liquidation, or winding up of Borrower or any
substantial portion of its business. As used herein, a “Change of Control” shall be deemed to occur upon the consummation
of any of the following events: (a) any Person or Persons acting together which would constitute a “group” for purposes of
Section 13(d) of the Exchange (other than Borrower or any Subsidiary of Borrower) shall beneficially own (as defined in Rule 13d-3
of the Exchange Act), directly or indirectly, at least fifty percent (50%) of the total voting power of all classes of capital stock of
Borrower entitled to vote generally in the election of the Board; (b) Current Directors (as herein defined) shall cease for any reason
to constitute at least a majority of the members of the Board (for this purpose, a “Current Director” shall mean any
member of the Board as of the date hereof and any successor of a Current Director whose election, or nomination for election by the Borrower's
shareholders, was approved by at least a majority of the Current Directors then on the Board); (c) (i) the complete liquidation of the
Borrower, or (ii) the merger or consolidation of the Borrower, other than a merger or consolidation in which (x) the holders of the Common
Stock of Borrower immediately prior to the consolidation or merger have, directly or indirectly, at least a majority of the Common Stock
of the continuing or surviving corporation immediately after such consolidation or merger, or (y) the Board immediately prior to the merger
or consolidation would, immediately after the merger or consolidation, constitute a majority of the board of directors of the continuing
or surviving corporation, which liquidation, merger or consolidation has been approved by the shareholders of the Borrower; (d) the sale
or other disposition (in one transaction or a series of transactions) of all or substantially all of the assets of Borrower pursuant to
an agreement (or agreements) which has (have) been approved by the shareholders of Borrower; or (e) the appointment of a new chief executive
officer.

 

    	 	13	 

     

    

 

4.1.11       Cessation
of Operations. Any cessation of operations by the Borrower or the Borrower admits it is otherwise generally unable to pay its debts
as such debts become due, provided, however, that any disclosure of the Borrower’s ability to continue as a “going concern”
shall not be an admission that the Borrower cannot pay its debts as they become due.

 

4.1.12       Maintenance
of Assets. The failure by Borrower to maintain any intellectual property rights, personal, real property or other assets which are
necessary to conduct its business (whether now or in the future), to the extent that such failure would result in a material adverse condition
or material adverse change in or affecting the business operations, properties or financial condition of Borrower or any of its Subsidiaries
(a “Material Adverse Effect”).

 

4.1.13       Financial
Statement Restatement. At any time after a Listing Event, Borrower restates any financial statements for any date or period from two
years prior to the Issue Date of this Note and until this Note is no longer outstanding, if the result of such restatement would, by comparison
to the unrestated financial statement, have constituted a material adverse effect on the rights of Holder with respect to this Note.

 

4.1.14       Failure
to Execute Transaction Documents or Complete the Transaction. The failure of the Borrower to execute any of the Transaction Documents
or to complete the transaction for the full Original Principal Amount of the Note.

 

4.1.15       Illegality.
Any court of competent jurisdiction issues an order declaring this Note, any of the other Transaction Documents or any provision hereunder
or thereunder to be illegal, as long as such declaration was not the result of an act of negligence by Holder, exclusive of the execution
of the Transaction Documents or the transactions and acts contemplated herein.

 

4.1.16       Cross-Default.
Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a breach or default
by the Borrower of any covenant or other term or condition contained in any of the other financial instruments, including but not limited
to all promissory notes, currently issued, or hereafter issued, by Borrower, to Holder or any other third party (the “Other Agreements”),
after the passage of all applicable notice and cure or grace periods, that results in a Material Adverse Effect shall, at the option of
Holder, be considered a default under this Note, in which event Holder shall be entitled to apply all rights and remedies of Holder under
the terms of this Note by reason of a default under said Other Agreement or hereunder.

 

4.1.17       Variable
Rate Transactions. The Borrower (i) enters into a Variable Rate Transaction (as defined herein), (ii) issues Common Stock(or convertible
securities or purchase rights) pursuant to an equity line of credit of the Borrower or otherwise in connection with a Variable Rate Transaction
(whether now existing or entered into in the future), or (iii) adjusts downward the “floor price” at which Common Stock (or
convertible securities or purchase rights) may be issued under an equity line of credit or otherwise in connection with a Variable Rate
Transaction (whether now existing or entered into in the future).

 

4.1.18       Certain
Transactions. Borrower enters into certain transactions prohibited by Section
3.3 of this Agreement.

 

    	 	14	 

     

    

 

4.1.19       Reverse
Splits. The Borrower effectuates a reverse split of its Common Stock without twenty (20) days prior written notice to Holder.

 

4.1.20       Replacement
of Transfer Agent. In the event that Borrower proposes to replace its transfer agent, the Borrower fails to provide, prior to the
effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions (including but not limited to the provision
to irrevocably reserve shares of Common Stock in the Reserved Amount) signed by the successor transfer agent to Borrower and the Borrower.

 

4.1.21       DTC
“Chill”. At any time on or after a Listing Event, the DTC places a “chill” (i.e. a restriction placed by DTC
on one or more of DTC’s services, such as limiting a DTC participant’s ability to make a deposit or withdrawal of the security
at DTC) on any of the Borrower’s securities.

 

4.1.22       DWAC
Eligibility. At any time on or after a Listing Event, in addition to the Event of Default in Section 4.1.21, the Common Stock is otherwise
not eligible for trading through the DTC’s Fast Automated Securities Transfer or Deposit/Withdrawal at Custodian programs, or if
the Borrower is not registered with DTC on the Issue Date, Borrower fails to become DTC registered within thirty (30) days of such listing
or quotation.

 

4.1.23       Bid
Price. At any time on or after a Listing Event, Borrower shall lose the “bid” price for its Common Stock ($0.0001 on the
“Ask” with zero market makers on the “Bid” per Level 2) and/or a market (including the OTC Pink, OTCQB or an equivalent
replacement marketplace or exchange).

 

 4.1.24       Inside Information. [RESERVED.]

 

 4.1.25       Intentionally Omitted.

 

 4.1.26       Intentionally Omitted.

 

 4.2       Remedies Upon Default.

 

(a)       Upon
the occurrence of any Event of Default specified in this Article IV, in addition to and without limitation of other remedies set forth
herein in this Note, (i) interest shall accrue on all amounts due under this Note at the Default Interest rate until payment in full of
such amounts, including following the entry of a judgment in favor of Holder; (ii) this Note shall become immediately due and payable,
all without demand, presentment or notice, all of which are hereby expressly waived by the Borrower, and Borrower shall pay to the Holder,
an amount (the “Default Amount”) equal to the Original Principal Amount then outstanding (including Monitoring Fees
defined below) plus accrued and unpaid interest through the date of the Event of Default, unaccrued interest through the Maturity Date
that is guaranteed pursuant to Section 1.2 above, together with all costs, including, without limitation, reasonable legal fees and expenses
of collection, and Default Interest through the date of full repayment. In addition, the Holder shall be entitled to exercise all other
rights and remedies available at law or in equity, including, without limitation, those set forth in the Related Documents.

 

    	 	15	 

     

    

 

 

(b)       Upon
the occurrence and during the continuation of an Event of Default, Borrower shall incur a monthly monitoring fee (“Monitoring
Fee”) in the amount of Ten Thousand Dollars and No Cents ($10,000.00) per month commencing in the month in which the Event of
Default occurs and continuing until the Event of Default is cured in order to cover the Holder’s costs of monitoring and legal expenses
and other expenses incurred by Holder.

 

ARTICLE V.
MISCELLANEOUS

 

5.1       Failure
or Indulgence Not Waiver. No failure or delay on the part of Holder in the exercise of any power, right or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative to, and
not exclusive of, any rights or remedies otherwise available.

 

5.2       Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and,
unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt
requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery,
telegram, facsimile, or electronic mail addressed as set forth below or to such other address as such party shall have specified most
recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a)
upon hand delivery, upon electronic mail delivery, or delivery by facsimile, with accurate confirmation generated by the transmitting
facsimile machine, at the address or number designated below (if delivered on a Business Day during normal business hours where such notice
is to be received), or the first Business Day following such delivery (if delivered other than on a Business Day during normal business
hours where such notice is to be received), or (b) on the second Business Day following the date of mailing by express courier service,
fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such
communications shall be:

 

If to the Borrower, to:

 

La Rosa Holdings Corp.

1420 Celebration Blvd., 2nd Floor Celebration,
FL 34747

kent@larosarealty.com

 

If to the Holder, to

 

Joseph La Rosa

1420 Celebration Blvd., 2nd Floor Celebration,
FL 34747

joe@larosarealty.com

 

5.3      Amendments.
This Note and any provision hereof may only be amended by an instrument in writing signed by Borrower and Holder. The term “Note”
and all reference thereto, as used throughout this instrument, shall mean this instrument as originally executed, or if later amended
or supplemented, then as so amended or supplemented.

 

    	 	16	 

     

    

 

5.4       Assignability.
This Note shall be binding upon Borrower and its successors and assigns, and shall inure to be the benefit of Holder and its successors
and assigns. Each transferee of this Note must be an “accredited investor” (as defined in Rule 501(a) of the Securities Act).

 

5.5       Withholding
Tax: In the event that there is any withholding tax due on any obligation of Holder, the obligation to pay such withholding tax shall
be divided equally by Borrower and Holder, and Borrower may deduct half of any such withholding tax from amounts due to Holder
upon providing Holder a confirmation of such withholding tax payment.

 

5.6       Cost
of Collection. If default is made in the payment of this Note, the Borrower shall pay Holder hereof costs of collection, including
attorneys’ fees. Such amounts spent by Holder shall be added to the Original Principal Amount of the Note at the time of such expenditure.

 

5.7       Governing
Law. This Note shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles
of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Note shall
be brought only in the state and/or federal courts located in Florida. The parties to this Note hereby irrevocably waive any objection
to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or
based upon forum non conveniens. THE BORROWER IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL
FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS NOTE OR ANY TRANSACTIONS CONTEMPLATED HEREBY.
The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and costs. In the event that any
provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute
or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified
to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process
and consents to process being served in any suit, action or proceeding in connection with this Note or any other Transaction Documents
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law..

 

5.8      Certain
Amounts. Whenever pursuant to this Note Borrower is required to pay an amount in excess of the outstanding Original Principal Amount
(or the portion thereof required to be paid at that time) plus accrued and unpaid interest plus Default Interest on such interest, Borrower
and Holder agree that the actual damages to Holder from the receipt of cash payment on this Note may be difficult to determine and the
amount to be so paid by Borrower represents stipulated damages and not a penalty.

 

    	 	17	 

     

    

 

5.9      Remedies.
Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable
harm to Holder, by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, Borrower acknowledges that the
remedy at law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach
by Borrower of the provisions of this Note, that Holder shall be entitled, in addition to all other available remedies at law or in equity,
and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this
Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without any bond
or other security being required.

 

5.10    Prepayment.
Unless an Event of Default shall occur, Borrower shall have the right at any time prior to the Maturity Date, upon thirty (30) days’
notice to the Holder (the “Prepayment Notice”), to prepay the Note by making a payment to Holder equal to one hundred
and ten percent (110%) multiplied by the sum of (i) the outstanding Original Principal Amount, and (ii) any other amounts due under
the Note (the “Prepayment Amount”). The Prepayment Notice must be received by Holder no later than thirty (30) days
prior to the date that Borrower proposes to remit the Prepayment Amount (the “Prepayment Date”). Holder may convert
any or all of this Note into shares of Common Stock prior to the Prepayment Date. If Borrower does not remit the Prepayment Amount within
two (2) days after the Prepayment Date, then (i) the Prepayment Notice and the Prepayment right granted hereunder shall be canceled, (ii)
Borrower shall thereafter not be permitted to prepay the Note, and (iii) Holder’s right to convert any or all of this Note into
shares of Common Stock shall be reinstated.

 

5.11    Usury.
To the extent it may lawfully do so, Borrower hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist
any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in
force, in connection with any action or proceeding that may be brought by Holder in order to enforce
any right or remedy under this Note. Notwithstanding any provision to the contrary contained in this Note, it is expressly agreed
and provided that the total liability of Borrower under this Note for payments which under Nevada law are in the nature of interest shall
not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the
foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums which under
Nevada law in the nature of interest that the Borrower may be obligated to pay under this Note exceed such Maximum Rate. It is agreed
that if the maximum contract rate of interest allowed by Nevada law and applicable to this Note is increased or decreased by statute or
any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum
Rate applicable to this Note from the effective date thereof forward, unless such application is precluded by applicable law. If under
any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Borrower to the Holder with respect to indebtedness
evidenced by this Note, such excess shall be applied by the Holder to the unpaid principal balance of any such indebtedness or be refunded
to the Borrower, the manner of handling such excess to be at Holder’s election.

 

5.12    Section
3(a)(10) Transactions. At any time after a Listing Event, and so long as this Note is outstanding, if Borrower enters into a transaction
structured in accordance with, based upon, or related or pursuant to, in whole or in part, Section 3(a)(10) of the Securities Act, then
a liquidated damages charge of twenty five percent (25%) of the outstanding Original Principal Amount of this Note at that time, will
be assessed and will become immediately due and payable to Holder, either in the form of cash payment or as an addition to the balance
of the Note, as determined by mutual agreement of the Borrower and Holder.

 

    	 	18	 

     

    

 

5.13    No
Broker-Dealer Acknowledgement. Absent a final adjudication from a court of competent jurisdiction stating otherwise, so long as
any obligation of Borrower under this Note or the other Transaction Documents is outstanding, the Borrower shall not state, claim,
allege, or in any way assert to any person, institution, or entity, that Holder is currently, or ever has been, a
broker-dealer under the Exchange Act.

 

5.14    Opportunity
to Consult with Counsel. Holder represents and acknowledges that it has been provided with the opportunity to discuss and review the
terms of this Note and the other Transaction Documents with its personal counsel before signing it and that it is freely and voluntarily
signing the Note and the other Transaction Documents in exchange for the benefits provided herein. Holder represents and acknowledges
that it has been provided a reasonable period of time within which to review the terms of the Note and the other Transaction Documents.
In light of this, Holder will not contest the validity of the Note and the otherTransaction Documents and the transactions contemplated
therein, and Holder represents and acknowledges that all parties hereto have participated in the preparation of this Note and the other
Transaction Documents. In any construction of the terms of the Note or the other Transaction Documents, the same shall not be construed
against either party on the basis of that party being the drafter of such terms.

 

 5.15     INTENTIONALLY OMITTED.

 

5.16    Integration.
This Note, along with the other Transaction Documents, constitute the entire agreement between the parties and supersedes all prior negotiations,
discussions, representations, or proposals, whether oral or written, unless expressly incorporated herein, related to the subject matter
of the Note. Unless expressly provided otherwise herein, this Note may not be modified unless in writing signed by the duly authorized
representatives of the Borrower and by Holder. If any provision or part thereof is found to be invalid, the remaining provisions will
remain in full force and effect.

 

[Signature page to follow]

 

    	 	19	 

     

    

 

IN WITNESS WHEREOF,
Borrower has caused this Note to be signed in its name by its duly authorized officer this December 2, 2022.

 

La Rosa Holdings Corp.

 

	By:	/s/ Kent Metzroth	 
	Name:	Kent Metzroth	 
	Title:	Executive Vice President and Chief Financial Officer Holder:	 

 

	By:	/s/ Joseph La Rosa	 
	Name:	Joseph La Rosa	 

 

    	 	20	 

     

    

 

EXHIBIT A

FORM OF NOTICE OF CONVERSION

 

CONVERSION
NOTICE

 

The undersigned hereby irrevocably elects
to convert $ _________________ of the Original Principal Amount (and accrued interest) of the above Note into shares of Common
Stock of LA ROSA HOLDINGS CORP. at the Fixed Conversion Price (as it may be adjusted) according to the terms and conditions of said Note.

 

Dated: _________________, 202_

 

	 	By:	 
	 	Name:	Joseph La Rosa
	 	Address:	1420 Celebration Blvd., 2nd Floor Celebration, FL 34747

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]